Tubular cells trans-differentiation induced by allogenic response can be modulated by cyclo-oxygenase-2 inhibitors

By Peruzzi L.   Amore A.   Cirina P.   Chiesa M.   Coppo R.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3349-3350

Elsevier

Access to resources Recommend Favorite

Cyclooxygenase2 inhibitors for nonsmallcell lung cancer: A phase II trial and literature review

By                        

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 744-750

Spandidos Publications

Access to resources Recommend Favorite

Cyclooxygenase-2: a therapeutic target in angiogenesis

By Iniguez M.A.   Rodrguez A.   Volpert O.V.   Fresno M.   Redondo J.M.  

Trends in Molecular Medicine, Vol. 9, Iss. 2, 2003-02 ,pp. : 73-78

Elsevier

Access to resources Recommend Favorite

Cyclooxygenase Inhibitors: Instrumental Drugs to Understand Cardiovascular Homeostasis and Arterial Thrombosis

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 8, Iss. 4, 2008-01 ,pp. : 268-277

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclooxygenase-2 and its role in colorectal cancer development

By Wendum Dominique  

Virchows Archiv, Vol. 445, Iss. 4, 2004-10 ,pp. : 327-333

Springer Publishing Company

Access to resources Recommend Favorite